Processa Pharmaceuticals Inc (NASDAQ: PCSA) established initial surge of 23.27% at $0.39, as the Stock market unbolted on Wednesday, before settling in for the price of $0.32 at the close. Taking a more long-term approach, PCSA posted a 52-week range of $0.15-$1.50.
The Healthcare sector firm’s twelve-monthly sales growth has been 22.65% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was 22.65%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 88.37%. This publicly-traded company’s shares outstanding now amounts to $50.35 million, simultaneously with a float of $43.77 million. The organization now has a market capitalization sitting at $19.60 million. At the time of writing, stock’s 50-day Moving Average stood at $0.2543, while the 200-day Moving Average is $0.3342.
Processa Pharmaceuticals Inc (PCSA) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Processa Pharmaceuticals Inc industry. Processa Pharmaceuticals Inc’s current insider ownership accounts for 13.07%, in contrast to 0.76% institutional ownership. According to the most recent insider trade that took place on Jan 27 ’25, this organization’s Director bought 12,400 shares at the rate of 0.80, making the entire transaction reach 9,889 in total value, affecting insider ownership by 12,400. Preceding that transaction, on Jan 27 ’25, Company’s Chief Executive Officer bought 87,200 for 0.80, making the whole transaction’s value amount to 69,542. This particular insider is now the holder of 87,200 in total.
Processa Pharmaceuticals Inc (PCSA) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.06 per share during the current fiscal year.
Processa Pharmaceuticals Inc’s EPS increase for this current 12-month fiscal period is 88.37% and is forecasted to reach -0.23 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 59.35% through the next 5 years, which can be compared against the 22.65% growth it accomplished over the previous five years trading on the market.
Processa Pharmaceuticals Inc (NASDAQ: PCSA) Trading Performance Indicators
Let’s observe the current performance indicators for Processa Pharmaceuticals Inc (PCSA). It’s Quick Ratio in the last reported quarter now stands at 3.45.
In the same vein, PCSA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.32, a figure that is expected to reach -0.08 in the next quarter, and analysts are predicting that it will be -0.23 at the market close of one year from today.
Technical Analysis of Processa Pharmaceuticals Inc (PCSA)
Now, what If we examine the latest scores posted by [Processa Pharmaceuticals Inc, PCSA]. During the last 5-days, its volume was lower the volume of 9.54 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 43.08% While, its Average True Range was 64.12.
Raw Stochastic average of Processa Pharmaceuticals Inc (PCSA) in the period of the previous 100 days is set at 36.93%, which indicates a major fall in contrast to 69.16% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.0527 that was higher than 0.0369 volatility it exhibited in the past 100-days period.
